Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration (Dry AMD)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Ocata Therapeutics Identifier:
First received: April 28, 2011
Last updated: October 21, 2015
Last verified: October 2015